Senior Research Scientist - Exosome Process Development
Bengaluru, India · Full time · Posted Oct 7, 2026
Role Overview
We are seeking a hands-on Senior Research Scientist to lead laboratory development of mammalian cell-culture and extracellular-vesicle (EV) production and purification methods. The position includes analytical characterization, process optimization, scale-up and technology transfer within Pandorum’s Cellular Engineering team.
Required Qualification
Ph.D. in Biotechnology, Cell Biology, Molecular Biology, Biochemistry, Bioengineering, Regenerative Medicine, Stem Cell Biology, Pharmacology, Neuroscience or a related life-science discipline.
3- 6yrs. of relevant experience is a must
Key Responsibilities
Perform biochemical, molecular and cell-based assays; analyze results and maintain complete laboratory records.
Design controlled experiments with predefined objectives, appropriate comparators and biological replication; retain complete records and critically assess all findings.
Develop and optimize mammalian cell-culture and upstream production processes, evaluating product yield, quality, consistency and biological activity.
Develop EV harvest, concentration and purification workflows; investigate recovery, purity and stability while preserving functional activity.
Apply cell-culture and molecular-biology techniques to laboratory development studies, using suitable analytical and cell-based assays.
Use structured experimental design to identify critical process variables, resolve variability and assess product comparability across development batches.
Support formulation, storage and scale-up studies; prepare technical transfer packages and work with internal teams and external partners on implementation.
Contribute to process and assay documentation supporting quality, manufacturing and regulatory activities appropriate to the development stage.
Own experimental plans and milestones, maintain SOPs and technical reports, communicate findings clearly and mentor junior team members.
Preferred Experience
Direct experience in EV biology, EV production, engineering or characterization.
Strong hands-on mammalian cell-culture, cell-biology and molecular-biology skills, with evidence of independent experimental design, troubleshooting and quantitative data interpretation.
Ability to perform and interpret biochemical or molecular characterization alongside quantitative cell-based assays, with clear documentation and scientific communication.
Demonstrated hands-on process-development experience with cell-derived EVs or related biologics, including production, purification and analytical characterization.
Experience in molecular biology, gene expression or biomolecular characterization, with practical competence in relevant analytical methods.
Evidence of improving process reproducibility and resolving experimental or analytical variability through controlled investigation.
Experience with tangential-flow filtration, chromatography, ultracentrifugation or other biological purification methods.
Experience with nanoparticle tracking analysis, immunoassays, qPCR/RT-qPCR, RNA/protein analysis or complementary characterization methods.
Experience with design of experiments, formulation, stability, scale-up, technology transfer or GMP environments; collaboration with CDMOs, CROs or analytical laboratories.
Ovii Interpretation
This Senior Research Scientist role develops mammalian cell-culture and extracellular-vesicle production and purification processes. The work spans analytical characterization, process optimization, scale-up and technology transfer, with hands-on laboratory execution and coordination across internal teams and external partners.
Role at a glance
Research scientistExtracellular-vesicle process developmentMammalian cell cultureLaboratory researchProcess optimizationScale-up and technology transfer
Develop and refine mammalian cell-culture and upstream production processes, assessing yield, quality, consistency and biological activity.
Build EV harvesting, concentration and purification workflows while evaluating recovery, purity, stability and retained function.
Run biochemical, molecular and cell-based assays; analyze findings and maintain complete laboratory records.
Plan controlled experiments and use results to identify process variables, investigate variability and compare development batches.
Support formulation, storage and scale-up studies, and prepare technical packages for process transfer.
Document processes and assays for quality, manufacturing and regulatory activities appropriate to the development stage.
Coordinate implementation with internal teams and external partners, and communicate findings while mentoring junior colleagues.
Good fit signals
Has a Ph.D. in a listed or related life-science discipline and 3–6 years of relevant experience.
Can plan and carry out laboratory studies and evaluate quantitative experimental results.
Direct EV biology, production, engineering or characterization experience is preferred, not stated as a mandatory qualification.
Hands-on process development involving EVs or related biologics is a preferred signal.
Experience with purification, analytical methods, scale-up, technology transfer, GMP or external laboratories may be useful.
Meet Pandorum
Pandorum Technologies is a Bengaluru-based biotechnology company developing programmable regenerative medicines and engineered human tissues. Founded in 2011, its platform combines biomaterials, cellular engineering, designer exosomes and biofabrication to promote tissue repair and regeneration. Its lead therapeutic, Kuragenx, is a cell-free exosome-based treatment for severe corneal diseases and has received US FDA Orphan Drug Designation. Pandorum also develops 3D human liver organoids for drug research and regenerative approaches for lung and other tissues. The company operates R&D activities in India and the United States and collaborates with clinical and manufacturing partners including Northwestern Medicine, Medical University of South Carolina and Nucelion Therapeutics.
Founded
2011
Company size
11-50 employees
Company stage
Not known
Headquarters
Bengaluru, India
Why work here
Pandorum offers scientists and engineers the opportunity to work on clinical-stage regenerative medicine spanning designer exosomes, stem-cell biology, biomaterials, organoids and advanced biofabrication. Its lead therapy Kuragenx has received US FDA Orphan Drug Designation, and the company raised an $18 million Series B in 2026 to advance clinical development and global manufacturing. Pandorum also collaborates with clinical and manufacturing organizations in India and the US. Its careers page lists health and life insurance, family medical coverage, annual health checks, mental-health support and competitive compensation, while emphasizing continuous learning. Candidates should also consider the long validation, regulatory and clinical-development cycles inherent to biotechnology.
TBTuhin BhowmickCo-Founder, CEO and DirectorView bioHide bio
Co-founder, CEO and Director. Bhowmick holds a PhD from the Indian Institute of Science and completed postdoctoral research at the European Molecular Biology Laboratory as an EMBO-Marie Curie fellow. His expertise includes biophysics, biomaterials, structural biology, protein biochemistry and computational biology.
ACArun ChandruCo-Founder, CTO and DirectorView bioHide bio
Co-founder, CTO and Director. Chandru completed research in Aerospace Engineering at the Indian Institute of Science, where he received a gold medal for best thesis. His expertise spans systems engineering, advanced manufacturing and biofabrication. He was named to Forbes Asia's 30 Under 30 Healthcare & Science list in 2016.
SRSridhar RanganathanSenior Advisor - Commercialization and Strategic PartnershipsView bioHide bio
Advises Pandorum on commercialization and strategic partnerships. Ranganathan has more than three decades of healthcare experience and previously served as Managing Director of Allergan India and Associate Vice President at Allergan International, with expertise in ophthalmology, medical devices and healthcare commercialization.
Pandorum and Nucelion manufacturing partnership to advance two designer-exosome programmes in ophthalmology
BioSpectrum India·
Pandorum and Bharat Biotech subsidiary Nucelion Therapeutics expanded their manufacturing partnership to support two PRIP-backed ophthalmology programs targeting advanced keratopathy and wet age-related macular degeneration. The programs use Pandorum's designer-exosome regenerative-medicine platform.
Pandorum Technologies raises $18 million in Series B to scale tissue regenerative therapies
ET Pharma·
Pandorum closed an $18 million Series B round to advance clinical development of Kuragenx and other tunable exosome-based therapies, expand manufacturing capacity and grow operations across the United States, Japan and the Middle East.
Pandorum Technologies and Nucelion Therapeutics announce strategic manufacturing collaboration for ocular regenerative therapies
Business Wire·
Pandorum partnered with Nucelion Therapeutics to build manufacturing capabilities for its exosome-based ocular regenerative therapies across Asia-Pacific, supporting clinical development, regional supply and regulatory readiness.